A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study.

A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study.

Item
http://www.wikidata.org/entity/Q48085570
Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito.Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndromeClinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract.Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal DysfunctionPharmacokinetic Profiles of Active Ingredients and Its Metabolites Derived from Rikkunshito, a Ghrelin Enhancer, in Healthy Japanese Volunteers: A Cross-Over, Randomized Study.Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn.Persistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients.Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy.Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial.Health-related quality of life prospectively evaluated by the 8-item short form after endovascular repair versus open surgery for abdominal aortic aneurysms.CRF receptor 1 antagonism and brain distribution of active components contribute to the ameliorative effect of rikkunshito on stress-induced anorexia.Physiological analysis of the effects of rikkunshito on acid and non-acid gastroesophageal reflux using pH-multichannel intraluminal impedance monitoring.Influence of food on the gastric motor effect of the Kampo medicine rikkunshito in rat.Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.
P2860

A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study.

Item
http://www.wikidata.org/entity/Q48085570
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A randomized, placebo-controll ...... inhibitor: the G-PRIDE study.
@en
A randomized, placebo-controll ...... inhibitor: the G-PRIDE study.
@nl
type
label
A randomized, placebo-controll ...... inhibitor: the G-PRIDE study.
@en
A randomized, placebo-controll ...... inhibitor: the G-PRIDE study.
@nl
prefLabel
A randomized, placebo-controll ...... inhibitor: the G-PRIDE study.
@en
A randomized, placebo-controll ...... inhibitor: the G-PRIDE study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
A randomized, placebo-controll ...... inhibitor: the G-PRIDE study.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921